Congenital adrenal hyperplasia historical perspective

Jump to navigation Jump to search

Congenital adrenal hyperplasia main page

Overview

Classification

21-hydroxylase deficiency
11β-hydroxylase deficiency
17 alpha-hydroxylase deficiency
3 beta-hydroxysteroid dehydrogenase deficiency
Cytochrome P450-oxidoreductase (POR) deficiency (ORD)
Lipoid congenital adrenal hyperplasia

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Historical Perspective

In 1563, Eustachius describes the adrenals (published by Lancisi in 1714). In 1849, Thomas Addison, while searching for the cause of pernicious anemia, stumbles on a bronzed appearance associated with the adrenal glands called melasma suprarenale In 1855, Thomas Addison describes the clinical features and autopsy findings in 11 cases of diseases of the suprarenal capsules, at least 6 of which were tuberculous in origin. In 1856, In adrenalectomy experiments, Brown-Séquard demonstrates that the adrenal glands are essential for life. In 1896, William Osler prepares an oral glycerin extract derived from pig adrenals and demonstrates that it has clinical benefit in patients with Addison disease. In 1905, Bulloch and Sequeira describe patients with congenital adrenal hyperplasia. In 1929, Liquid extracts of cortical tissue are used to keep adrenalectomized cats alive indefinitely (Swingle and Pfiffner); subsequently, this extract was used successfully to treat a patient with Addison disease (Rowntree and Greene). In 1932, Harvey Cushing associates the polyglandular syndrome of pituitary basophilism, which he first described in 1912, with hyperactivity of the pituitary-adrenal glands. In 1936,The concept of stress and its effect on pituitary-adrenal function are described by Selye. In 1937-1952,Isolation and structural characterization of adrenocortical hormones are reported by Kendall and Reichstein. In 1943, Li and colleagues isolate pure adrenocorticotropic hormone from sheep pituitary. In 1950, Hench, Kendall, and Reichstein share the Nobel Prize in Medicine for describing the anti-inflammatory effects of cortisone in patients with rheumatoid arthritis. In 1953,Isolation and analysis of the structure of aldosterone are reported by Simpson and Tait. In 1956, Conn describes primary aldosteronism. In 1981, Characterization and synthesis of corticotropin-releasing hormone are reported by Vale. From 1980-present the molecular era: cloning and functional characterization of steroid receptors, steroidogenic enzymes, and adrenal transcription factors are reported, and the molecular basis for human adrenal diseases is defined.

References


Template:WikiDoc Sources